Skip to content

AbbVie ABBV Intangible assets — net

Intangible assets — net at other companies

McKesson logo
McKessonMCK
$4.08B+179%
Pfizer logo
PfizerPFE
Amgen logo
AmgenAMGN
The Cooper Companies, Inc. logo
The Cooper Companies, Inc.COO
Cardinal Health logo
Cardinal HealthCAH
Bausch Health Companies logo
Bausch Health CompaniesBHC

Other financials

Income statement

See full
Revenue$15.0B+12.4%
Gross profit$10.8B+15.4%
Operating income$4.0B+6.9%
Net income$695.0M-46.0%
EPS (diluted)$0.39-45.8%

Balance sheet

See full
Cash & equivalents$9.4B+81.5%
Total debt$62.4B+1.8%
Total equity-$6.7B-569%
Total assets$136.46B+0.2%

Cash flow

See full
Operating cash flow$3.8B+134%
CapEx$265.0M+12.8%
Free cash flow$3.6B+155%

Valuation

See full
Market cap$415B+3.8%
P/E114.2×+18.9×
P/S6.6×-0.4×

Profitability

See full
Gross margin70.7%0.0pp
Operating margin24.4%
Net margin5.8%-1.5pp
FCF margin31.8%+5.0pp

Returns & leverage

See full
Return on equity89%+32.7pp
Debt / equity46.6×+38.6×
Current ratio0.8×0.0×

Where this comes from

Reported directly by AbbVie in its filing.

Tagged under the XBRL concept us-gaap:FiniteLivedIntangibleAssetsNet.

The official record: AbbVie’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about AbbVie's intangible assets — net.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is AbbVie's intangible assets — net?
AbbVie (ABBV) reported intangible assets — net of $45.6B in Q1 2026.
How has AbbVie's intangible assets — net changed year-over-year?
AbbVie's intangible assets — net decreased by 14.3% year-over-year, from $53.2B to $45.6B.
What is the long-term trend for AbbVie's intangible assets — net?
Over 5 years (2020 to 2025), AbbVie's intangible assets — net has grown at a -10.2% compound annual growth rate (CAGR), from $81B to $47.36B.